000 01276 a2200349 4500
005 20250515041736.0
264 0 _c20061020
008 200610s 0 0 eng d
022 _a0013-9580
024 7 _a10.1111/j.1528-1167.2006.00843_2.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerrotti, Alberto
245 0 0 _aBone metabolism and vitamin D levels in carbamazepine-treated patients.
_h[electronic resource]
260 _bEpilepsia
_cSep 2006
300 _a1586; author reply 1586-7 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAnticonvulsants
_xadverse effects
650 0 4 _aBone Development
_xdrug effects
650 0 4 _aBone Resorption
_xchemically induced
650 0 4 _aBone and Bones
_xdrug effects
650 0 4 _aCarbamazepine
_xadverse effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEpilepsy
_xblood
650 0 4 _aHumans
650 0 4 _aVitamin D
_xblood
650 0 4 _aVitamin D Deficiency
_xchemically induced
700 1 _aMatricardi, Sara
700 1 _aManco, Rossella
700 1 _aChiarelli, Francesco
773 0 _tEpilepsia
_gvol. 47
_gno. 9
_gp. 1586; author reply 1586-7
856 4 0 _uhttps://doi.org/10.1111/j.1528-1167.2006.00843_2.x
_zAvailable from publisher's website
999 _c16560910
_d16560910